Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 16;13(1):22424.
doi: 10.1038/s41598-023-49789-5.

Abnormal neutrophil-to-lymphocyte ratio in children with autism spectrum disorder and history of maternal immune activation

Affiliations

Abnormal neutrophil-to-lymphocyte ratio in children with autism spectrum disorder and history of maternal immune activation

Pierre Ellul et al. Sci Rep. .

Abstract

Maternal immune activation (MIA), related to autoimmune/inflammatory diseases or acute infections, during the two first trimesters of pregnancy is a risk factor for autism spectrum disorders (ASD) in offspring. In mice, MIA has a long-term impact on offspring's immune equilibrium resulting in a pro-inflammatory phenotype. We therefore hypothesized that children with ASD and a history of MIA could display a similar phenotype specifically assessed by a higher neutrophil to lymphocyte ratio (NLR). In this study, we used a retrospective sample of 231 dyads involving children with ASD and their mothers. Among ASD patients, 12% had a history of MIA. The multivariate analysis revealed a significant association between NLR in children with ASD and maternal history of MIA (F = 2.27, p = 0.03). Using a categorical approach, we observed an abnormal NLR (over 3) in 7.4% of children with ASD MIA+ compared to 1.9% for MIA-. Our study supports the hypothesis suggesting an impact of MIA on the risk of ASD. Further studies could contribute to the development of biomarkers in MIA+ ASD and enable the development of targeted immunomodulatory therapies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nat. Rev. Dis. Primer. 2020;6:5. doi: 10.1038/s41572-019-0138-4. - DOI - PMC - PubMed
    1. Maenner MJ, Shaw KA, Baio J, et al. Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2016. Morb. Mortal Wkly. Rep. Surveill. Summ. Wash. DC. 2020;69:1–12. doi: 10.15585/mmwr.ss6904a1. - DOI - PMC - PubMed
    1. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. (American Psychiatric Association, 2013).
    1. Schaaf CP, Betancur C, Yuen RKC, et al. A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat. Rev. Genet. 2020;21:367–376. doi: 10.1038/s41576-020-0231-2. - DOI - PMC - PubMed
    1. Han VX, Patel S, Jones HF, Dale RC. Maternal immune activation and neuroinflammation in human neurodevelopmental disorders. Nat. Rev. Neurol. 2021;17:564–579. doi: 10.1038/s41582-021-00530-8. - DOI - PubMed

LinkOut - more resources